NMDA receptor antagonists (Shionogi)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNMDA receptor antagonists (Shionogi)
Drug Alias Nameisoxazole derivatives (Shionogi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 antagonists
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A